PROphylaxis for ThromboEmbolism in Critical care Trial (PROTECT) pilot study
Latest Information Update: 26 Sep 2022
At a glance
- Drugs Dalteparin sodium (Primary) ; Heparin
- Indications Deep vein thrombosis; Thromboembolism
- Focus Therapeutic Use
- Acronyms PROTECT